Author:
Asano Michiko,Okada Hiroshi,Itoh Yohji,Hirata Hajime,Ishikawa Kensuke,Yoshida Erika,Matsui Akiko,Kelly Elizabeth J.,Shoemaker Kathryn,Olsson Urban,Vekemans Johan
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference36 articles.
1. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate;Addetia;J Clin Microbiol,2020
2. AstraZeneca. AZD1222 US Phase III primary analysis confirms safety and efficacy. AstraZeneca; 2021. Available at: https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html (accessed 9 July 2021).
3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021
4. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses;Barrett;Nat Med,2021
5. Aging in COVID-19: vulnerability, immunity and intervention;Chen;Ageing Res Rev,2021
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献